Women and Mental Health

The Early Psychosis Intervention Network (EPINET), supported by NIMH, has expanded its reach, improving access to treatment and research resources for early psychosis care. By connecting regional hubs and clinics, the initiative provides data-driven, coordinated care for individuals experiencing early psychosis. EPINET aims to ensure that patients receive the best research-based treatment, improvi...

A study highlighted disparities in the diagnosis of psychotic disorders across racial and ethnic groups in the U.S. Black, American Indian, and Alaskan Native individuals were diagnosed with psychotic disorders at higher rates, leading to poorer mental and physical health outcomes, including comorbid conditions and reduced health care access. These findings stress the need for equitable mental hea...

A study identified a neural marker linked to social impairment in people with psychotic disorders like schizophrenia. Reduced brain activity in specific regions, such as the ventral striatum and orbital frontal cortex, was associated with social anhedonia—a lack of interest in social connections. This finding may lead to improved diagnosis and treatment of social difficulties in psychotic disorder...

An NIH study identified shared genetic markers across multiple substance use disorders, including alcohol, nicotine, cannabis, and opioid use. By analyzing genomic data from over a million individuals, the researchers found links between these disorders and dopamine regulation genes. The findings may lead to improved treatment and prevention strategies for substance use disorders.

A large NIMH-supported genetic study identified rare variants in 10 genes that significantly increase the risk of developing schizophrenia. These genes are involved in critical brain functions, such as neuronal communication and synaptic functioning. Understanding these genetic variations may lead to new treatment targets for this mental disorder, offering hope for better therapeutic options in th...

A NIH-supported study demonstrated that long-acting antiretroviral therapy (LA-ART) effectively suppressed HIV in people facing housing instability, mental illness, and substance use disorder. The study found that injectable LA-ART, combined with support services, helped these underserved individuals achieve virologic suppression, highlighting its potential to overcome treatment barriers in this v...

A study using Medicaid data revealed significant differences in mental health care across U.S. states and regions. The analysis highlighted disparities in access to outpatient services and the frequent use of emergency departments for mental health conditions, indicating unmet needs in certain areas. These findings emphasize the importance of tailored, localized strategies to improve mental health...

The RAISE initiative led to the rapid adoption of Coordinated Specialty Care (CSC) programs for early schizophrenia treatment in the U.S. These programs significantly improve outcomes for individuals experiencing their first episode of psychosis, focusing on recovery and integration into work or school. The initiative has revolutionized schizophrenia care, with CSC programs now operating nationwid...

Suicide is one of the leading causes of death in the U.S. NIMH has invested in large-scale research to improve suicide risk screening, assessment, and intervention. Universal suicide risk screening, coupled with follow-up care, has been shown to significantly reduce suicide attempts. NIMH continues to prioritize research that translates into practical, lifesaving tools for healthcare providers.

An NIMH-funded study explored the availability and structure of mental telehealth services post-pandemic. Researchers surveyed over 1,900 outpatient facilities, finding that 80% offered telehealth services, with varied access to counseling, medication management, and diagnostic care. The study revealed disparities in telehealth service availability based on location and type of facility, highlight...

A new study highlights the potential of collaborative care in reducing disparities in mental health treatment, especially for racial and ethnic minority groups. By using a patient-centered approach and tailoring care to individual needs, the study found significant reductions in PTSD symptoms. This intervention shows promise for addressing gaps in mental health care access and outcomes.

Research from NIMH revealed that fluctuations in estrogen can alter the function of a key brain memory circuit in women with a specific gene variant. This hormone-gene interaction may help explain individual differences in memory and susceptibility to mood and anxiety disorders. The findings shed light on how sex hormones influence mental health, especially during reproductive phases.

Research has linked high maternal inflammation during pregnancy to changes in a child’s brain development, including reduced brain connectivity and poorer cognitive functions. The findings suggest that maternal inflammation can influence the brain’s wiring, which may increase the risk of mental health disorders such as autism and ADHD in children.

Brexanolone, the first FDA-approved drug specifically for postpartum depression, emerged from decades of NIMH-supported research. It was developed based on understanding how allopregnanolone, a hormone that decreases after childbirth, influences mood. Brexanolone restores this hormone’s levels, offering rapid relief from postpartum depression symptoms.

NIMH experts are available to discuss various mental health issues arising from the COVID-19 pandemic, including anxiety, stress, and isolation. They provide guidance on managing mental health during these uncertain times, especially for individuals with pre-existing mental health conditions. NIMH highlights the importance of mental health support during the pandemic, offering resources for both a...

A study found a threefold increase in documented suicidality among childbearing women between 2006 and 2017. Suicidal thoughts and self-harm were more common after childbirth, with nearly 92% of those affected having co-occurring mental health conditions like anxiety or depression. The findings highlight the need for improved screening and treatment during and after pregnancy to reduce suicide ris...

A study found that women who experienced sexual assault or workplace harassment are more likely to develop high blood pressure, a risk factor for cardiovascular disease. The study suggests that multiple exposures to sexual violence have compounding effects on women’s cardiovascular health, highlighting the importance of addressing the long-term health impacts of such experiences.

A study in Kenya explored factors affecting the use of pre-exposure prophylaxis (PrEP) among young women at high risk of HIV. Barriers included stigma, mistrust, and social perceptions, while supports involved community awareness and personal responsibility. These findings highlight the importance of addressing multi-level challenges to improve HIV prevention in vulnerable populations.

A large population study highlights the differences in the onset and recurrence of depression before, during, and after pregnancy. The study found higher rates of first-time depression episodes postpartum and in the second trimester, showing that pregnancy and postpartum are critical periods for maternal mental health. These findings suggest the need for expanded mental health care throughout and...

A study funded by the NIH found that high maternal stress during pregnancy combined with prenatal COVID-19 infection may negatively impact an infant’s attention span and socioemotional development. These findings suggest managing stress during pregnancy could reduce the risk of developmental delays.

A large NIH-funded study shows that a cognitive behavioral therapy (CBT) intervention significantly reduced the risk of postpartum anxiety and depression by over 70% in women from low-resource settings. The study highlights the potential of non-specialized providers delivering CBT to help address mental health needs during and after pregnancy.

Postpartum depression (PPD) affects many new mothers, often due to a drop in the neurosteroid allopregnanolone after childbirth. Decades of NIMH-supported research led to the development of brexanolone, the first drug approved to treat PPD. Brexanolone mimics the effects of allopregnanolone, offering fast and effective relief from PPD symptoms, representing a major breakthrough in mental health tr...

Suicide is a complex but preventable public health issue, often linked to mental health conditions like depression. Warning signs include talking about wanting to die, feeling hopeless, or withdrawing from loved ones. Effective suicide prevention involves recognizing these signs, offering support, and connecting individuals with mental health care. Treatments include therapy, safety planning, and...

Schizophrenia is a chronic mental disorder that affects a person’s thinking, behavior, and emotions. It often involves symptoms such as hallucinations, delusions, and cognitive difficulties, which can significantly disrupt daily life. Treatment typically includes antipsychotic medications and psychosocial therapies, helping individuals manage symptoms and improve functioning.

PTSD is a mental health disorder that develops in some individuals after experiencing or witnessing traumatic events. Symptoms include flashbacks, nightmares, severe anxiety, and uncontrollable thoughts about the event. PTSD can be treated with psychotherapy and medications, helping individuals manage symptoms and improve their quality of life.